Show source-provided references
4. Interactions between commensal intestinal bacteria and the immune system
10.1038/nri1373 ↗5. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease
10.1111/bph.14095 ↗8. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats
10.1039/D2FO01009G ↗10. Protective effect of selenium-polysaccharides from the mycelia of Coprinus comatus on alloxan-induced oxidative stress in mice
10.1016/j.foodchem.2009.03.073 ↗11. Selenium-containing polysaccharides from Ziyang green tea ameliorate high-fructose diet induced insulin resistance and hepatic oxidative stress in mice
10.1039/C5FO00557D ↗14. Gut Microbiome and Metabolomics Study of Selenium-Enriched Kiwifruit Regulating Hyperlipidemia in Mice Induced by a High-Fat Diet
10.1021/acs.jafc.3c00108 ↗15. Chen, Y., Liu, Y., Dong, Q., Xu, C., Deng, S., Kang, Y., Fan, M., and Li, L. (2023). Application of functionalized chitosan in food: A review. Int. J. Biol. Macromol., 235.
10.1016/j.ijbiomac.2023.123716 ↗17. Low molecular weight chitosan oligosaccharides (LMW-COSs) prevent obesity-related metabolic abnormalities in association with the modification of gut microbiota in high-fat diet (HFD)-fed mice
10.1039/D0FO01871F ↗19. Zhang, G., Zhang, M., Pei, Y., Qian, K., Xie, J., Huang, Q., Liu, S., Xue, N., Zu, Y., and Wang, H. (2023). Enhancing stability of liposomes using high molecular weight chitosan to promote antioxidative stress effects and lipid-lowering activity of encapsulated lutein in vivo and in vitro. Int. J. Biol. Macromol., 253.
10.1016/j.ijbiomac.2023.126564 ↗20. N-trimethyl chitosan coated targeting nanoparticles improve the oral bioavailability and antioxidant activity of vitexin
10.1016/j.carbpol.2022.119273 ↗21. Peng, S.-J., Ye, D.-T., Zheng, J., Xue, Y.-R., Lin, L., Zhao, Y.-D., Miao, W.-H., Song, Y., Wen, Z.-S., and Zheng, B. (2022). Synthesis, characterization of low molecular weight chitosan selenium nanoparticles and its effect on dss-induced ulcerative colitis in mice. Int. J. Mol. Sci., 23.
10.3390/ijms232415527 ↗22. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: Distinct clinicopathologic meanings
10.1002/hep.24127 ↗25. Oat bran prevents high-fat-diet induced muscular dysfunction, systemic inflammation and oxidative stress through reconstructing gut microbiome and circulating metabolome
10.1016/j.foodres.2023.113127 ↗27. Phlorizin ameliorates obesity-associated endotoxemia and insulin resistance in high-fat diet-fed mice by targeting the gut microbiota and intestinal barrier integrity
10.1080/19490976.2020.1842990 ↗28. Chitosan oligosaccharide mitigates kidney injury in prediabetic rats by improving intestinal barrier and renal autophagy
10.1016/j.carbpol.2022.119405 ↗29. Heptamethoxyflavone Alleviates Metabolic Syndrome in High-Fat Diet-Fed Mice by Regulating the Composition, Function, and Metabolism of Gut Microbiota
10.1021/acs.jafc.3c01881 ↗30. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity
10.1073/pnas.1219451110 ↗31. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice
10.1038/s41564-021-00880-5 ↗32. Akkermansia muciniphila inhibits nonalcoholic steatohepatitis by orchestrating TLR2-activated γδT17 cell and macrophage polarization
10.1080/19490976.2023.2221485 ↗33. Genus unclassified_Muribaculaceae and microbiota-derived butyrate and indole-3-propionic acid are involved in benzene-induced hematopoietic injury in mice
10.1016/j.chemosphere.2022.137499 ↗34. Effects of fermented wheat bran and yeast culture on growth performance, immunity, and intestinal microflora in growing-finishing pigs
10.1093/jas/skab308 ↗35. Dietary Chito-oligosaccharides Improve Intestinal Immunity via Regulating Microbiota and Th17/Treg Balance-Related Immune Signaling in Piglets Challenged by Enterotoxigenic E. coli
10.1021/acs.jafc.1c06029 ↗36. Yoon, S.J., Yu, J.S., Min, B.H., Gupta, H., Won, S.-M., Park, H.J., Han, S.H., Kim, B.-Y., Kim, K.H., and Kim, B.K. (2023). Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis. Front. Microbiol., 14.
10.3389/fmicb.2023.1129904 ↗37. Procyanidin B2 prevents dyslipidemia via modulation of gut microbiome and related metabolites in high-fat diet fed mice
10.1016/j.jff.2020.104285 ↗38. Polysaccharide from Ziyang Selenium-Enriched Green Tea Prevents Obesity and Promotes Adipose Thermogenesis via Modulating the Gut Microbiota
10.1021/acs.jafc.3c04193 ↗39. Yang, L., Wang, Y., Zheng, G., Li, Z., and Mei, J. (2023). Resveratrol-loaded selenium/chitosan nano-flowers alleviate glucolipid metabolism disorder-associated cognitive impairment in Alzheimer's disease. Int. J. Biol. Macromol., 239.
10.1016/j.ijbiomac.2023.124316 ↗40. Ran, Q., Gan, Q., Zhu, Y., Song, L., Shen, L., Duan, X., Zhu, X., and Huang, W. (2024). Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD). Biomed. Pharmacother., 173.
10.1016/j.biopha.2024.116322 ↗43. CD36 plays a negative role in the regulation of lipophagy in hepatocytes through an AMPK-dependent pathway
10.1194/jlr.M090969 ↗44. Nano-selenium supplements in high-fat diets relieve hepatopancreas injury and improve survival of grass carp Ctenopharyngodon Idella by reducing lipid deposition
10.1016/j.aquaculture.2021.736580 ↗45. Tao, W., Sun, W., Liu, L., Wang, G., Xiao, Z., Pei, X., and Wang, M. (2019). Chitosan Oligosaccharide Attenuates Nonalcoholic Fatty Liver Disease Induced by High Fat Diet through Reducing Lipid Accumulation, Inflammation and Oxidative Stress in C57BL/6 Mice. Mar. Drugs, 17.
10.3390/md17110645 ↗46. (-)-Epicatechin protects the intestinal barrier from high fat diet-induced permeabilization: Implications for steatosis and insulin resistance
10.1016/j.redox.2017.11.002 ↗48. Biomimetic MicroRNAs-Selenium-Nanocomposites for Targeted and Combined Hyperlipidemia Therapy
10.1002/adhm.202400064 ↗49. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: Involvement of soluble mediators
10.1136/gut.2007.140806 ↗51. Intestinal Barrier Function–Non-alcoholic Fatty Liver Disease Interactions and Possible Role of Gut Microbiota
10.1021/acs.jafc.9b00080 ↗54. Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion
10.1080/19490976.2022.2152307 ↗56. Qian, M., Lyu, Q., Liu, Y., Hu, H., Wang, S., Pan, C., Duan, X., Gao, Y., Qi, L.-W., and Liu, W. (2019). Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice. Mar. Drugs, 17.
10.3390/md17070391 ↗57. Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice
10.1039/D3FO03745B ↗58. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway
10.1007/s12011-022-03247-x ↗60. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study
10.1038/s41591-019-0495-2 ↗63. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways
10.1039/C9FO02905B ↗64. Ferulic acid improves intestinal barrier function through altering gut microbiota composition in high-fat diet-induced mice
10.1007/s00394-022-02927-7 ↗65. Preventive Effects of Apple Polyphenol Extract on High-Fat-Diet-Induced Hepatic Steatosis Are Related to the Regulation of Hepatic Lipid Metabolism, Autophagy, and Gut Microbiota in Aged Mice
10.1021/acs.jafc.3c00596 ↗67. Flavonoids from Whole-Grain Oat Alleviated High-Fat Diet-Induced Hyperlipidemia via Regulating Bile Acid Metabolism and Gut Microbiota in Mice
10.1021/acs.jafc.1c01813 ↗68. Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
10.1136/gutjnl-2017-314307 ↗71. Inhibition of microbial deconjugation of micellar bile acids protects against intestinal permeability and liver injury
10.1126/sciadv.abo2794 ↗73. Dietary acetic acid suppress high-fat diet-induced obesity in mice by altering taurine conjugated bile acids metabolism
10.1016/j.crfs.2022.10.021 ↗74. Metabolomic signatures for liver tissue and cecum contents in high-fat diet-induced obese mice based on UHPLC-Q-TOF/MS
10.1186/s12986-021-00595-8 ↗75. Li, H., Xi, Y., Xin, X., Tian, H., and Hu, Y. (2020). Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota–bile acid–farnesoid X receptor axis. Biomed. Pharmacother., 124.
10.1016/j.biopha.2020.109915 ↗76. Song, Z., Cai, Y., Lao, X., Wang, X., Lin, X., Cui, Y., Kalavagunta, P.K., Liao, J., Jin, L., and Shang, J. (2019). Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome, 7.
10.1186/s40168-019-0628-3 ↗78. Analysis of serum lysophosphatidylethanolamine levels in patients with non-alcoholic fatty liver disease by liquid chromatography-tandem mass spectrometry
10.1007/s00216-020-02996-9 ↗79. Phenolamide extract of apricot bee pollen alleviates glucolipid metabolic disorders and modulates the gut microbiota and metabolites in high-fat diet-induced obese mice
10.1039/D3FO01016C ↗